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Abstract
Introduction: Schizophrenia is a complex clinical syndrome that 
may present with a great variety of psychopathologic manifestations, 
covering changes in thought, perception and emotions, as well as 
motricity and behavioral abnormalities. It symptoms can be divided 
in positive and negative. Many others psychiatric disturbances share 
schizophrenia symptoms, among then, Schizoaffective Disorder, with 
altered mood, as in depression or mania. Although there is, in litera-
ture, plenty of evidence about the impact of depressive symptoms in 
the quality of life in schizophrenic patients, we were unable to identify 
Brazilian prospects on the subject. Surpassing the findings of other 
studies, depression in schizophrenic patients has considerable impacts, 
in addition to its prevalence and frequent underdiagnosis.
Objectives: Report a case of patient with Schizoafective Schizophre-
nia and Depression, treated in the Psycosocial Care Center (CAPES) III 
in the city of Juazeiro do Norte, Ceará, Brazil.
Materials and Methods: Case study, with an descriptive transversal 
approach, realized under the rules of Resolution 466/12, from National 
Health Council /National Health Ministry regarding legal and ethical 
aspects about studies with human beings. The study was registered 
in the Plataform Brasil, and subsequently forwarded for consideration 
in the Research Ethics Committee, then being approved.
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Indtroduction
Schizophrenia is a complex clinical syndrome, with a 
great variety of psychopathological manifestations, 
covering alterations in thought, perception and 
emotions, as well as motricity and behavioral ab-
normalities. It symptoms can be divided in positives 
(delirium, hallucinations, catatonia, etc.) and negati-
ves (blunted affect, alogia, avolition, etc.), that may 
predominate according to patient’s previous cha-
racteristics and time of disease; in as much, chro-
nic cumulative effects of schizophrenia tends to be 
severe and persistent, with marked social prejudice 
for those committed [1].
According to Aguiar et al (2010), the etiology of 
schizophrenia remains unknown and, however the-
re are many theories, there is still no consensus. 
The peak of incidence is of 15 to 25 years of age 
for man, and 25 to 35 years of age for woman [2]. 
Treatment must be continuous and is recommended 
for all diagnosed patients [3] (FALKAI, et al, 2006). 
Antipsychotic drugs have proven to be beneficial for 
most of psychotic disturbances, but it may be asso-
ciated with many undesirable effects [4] (HADAD, 
SHARMA, 1995).
Many other disturbances shares the carachteristics 
of schizophrenia [5]. Psychotic disturbances similar 
to schizophrenia, but with less than six months of 
symptoms are called Schizophreniform Disorders. At 
initial presentation, it is hard to tell with the patient 
will have a final diagnosis of schizophrenia or schi-
zophreniform disorder. (Esquizofrenia e Transtornos 
Psicóticos, 2015). When symptoms are present for 
Discussion: The patient’s life story and background, as reported 
by herself, can probably not only justify, but also fundaments the 
disease etiology. Attempts of sexual abuse, familiar negligence, psy-
chiatric disorders in the family, among many other factors, reported 
by the patient and her relatives, can be potential triggers for her schi-
zophrenia and depression. With new therapeutic approaches, body 
and psychic improvements begun, and the patients realized that a 
more healthy life, followed by weigh loss, despite medication usage; 
in association, the doctor patient-patient relationship has grown in 
confidence along the way. Finally this case shows the importance 
of this kind of approach, holistic and focused in the individual, for 
schizophrenic patients and other psychiatric disorders, because only 
that way the health care professional can maximize the results of the 
prescribed therapy.
Conclusions: Throughout this clinical case its possible to know and 
understand more about the Schizophrenic Disorders. We conclude 
that the therapeutic approach, executed by a multidisciplinary team, 
had a positive impact on patient’s prognosis. In practical terms, the 
best kind of assistance is the individualized and humanized, understan-
ding the uniqueness of every patient, respecting them and providing 
qualified assistance for their biopsychosocial needs.
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more than a day but less than a month, it can be 
classified as a Brief Psychotic Disorders, and usually 
is triggered by stressing situations [6] 
Psychiatric disorder characterized by the presence 
of humor alterations, as depression or mania, along 
with typical symptoms of schizophrenia is classified 
as a Schizoaffective Disorder [5]. 
According to Souza and Coutinho (2006), at-
tention must be raised in schizophrenic patients 
presenting anxiety and depressive symptoms, con-
sidering that those manifestations usually have the 
same –or even greater– impact on their quality life 
than negative and positive symptoms of schizophre-
nia. Specific therapeutic approach to those patients 
may implicate considerable improvement in quality 
of life [1].
In the Portugal Psychiatric Census, those patients 
searched more frequently for Health Care Services 
(21,2%) and, paired with depression, Eschizophrenia 
is responsible for 60% of the country’s suicide’s rate 
[7]. Internationally, the prevalence of depression in 
schizophrenic patients varies from 7 to 70%, me-
dia of 25%. In Brazil, the prevalence is estimated 
to be around 27 to 29,8% [8]. Despite its clinical 
relevance, the studies estimates that about half of 
the cases of depression are not diagnosed in the 
primary levels of health care services [9].
Even though the literature has established the im-
pact of depressive symptoms in the quality of life 
in the patients with schizophrenia, we were unable 
to identify Brazilian data on the subject. The sub-
jective is pertinent when considered the therapeutic 
approaches, including drug’s prescription, and its 
positive impact on these specific population when 
depression is precociously identified [10]. With pro-
per treatment, morbimortality associated with de-
pression can decrease about 70% [11].
Souza and Coutinho (2006) stated that Schizo-
phrenia is a paradigmatic disease in Psychiatry. The 
progressive transformation of psychiatric assistance 
is still faced with the idea that the evolution of men-
tal disorders depends solely on the classic variables 
related to the biomedical model, already outdated, 
ignoring all the biopsychosocial context in which 
the carrier is inserted. This concept shall be overco-
me permanently [1, 12].
Considering this background and the positive 
impacts of the interventions, it is important to 
deepen the studies on depression and schizo-
phrenia. In this article, we report a case of a pa-
tient suffering from Schizoaffective Schizophrenia 
in psychiatric treatment at the Centro de Atenção 
Psicossocial III (CAPES), in the city of Juazeiro do 
Norte –Ceará. 
Schizophrenia is a complex disease, with multiple 
causes and contexts, some of them still undifinied 
–which reinforces the importance of study it more. 
A compilation of case studies about schizophrenia 
and depression could be a valious source of infor-
mation about schizophrenia, helpening to clarify 
some points and favoring construction of consen-
sus about it’s etiology, pathophysiology, therapeutic 
management and prognosis. 
Our study considered, as initial question: Being 
schizophrenia a multifactorial disease, what were 
the causes that triggered the disease in the patient, 
specifically with an schizoid spectrum?
The relevance of the study lies in the instruments 
it can provide for the investigation of schizoid schi-
zophrenia, throughout a clinical report, with an hu-
manized focus to the biopsychosocial of the patient. 
We hope to contribute for the dissemination of 
theme and its study, raising its visibility, considering 
the rareness of reports about the professional ap-
proach with those patients, despite numerous stu-
dies about objective definitions 
We assume, as a hypotesis, that social, familial 
and religious influences, but especially the violent 
background on the patient’s story have act as tri-
ggers for schizophrenia, reinforce the multifactorial 
theory for the origin of schizophrenia and depres-
sion.
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Objectives
To report a case of a patient diagnosed with Schi-
zoaffective Schzophrenia and depression, following 
treatment in the Centro de Atenção Psicossocial III 
in the city of Juazeiro do Norte, Ceará, Brazil. Des-
cribe associated factors to the raise of schizophre-
nia for the considered patients, including its familial 
relations. Understand the importance of drug the-
rapy in the treatment of schizophrenia. Review the 
literature about the main therapeutic strategies for 
improving quality of life of schizophrenic patients. 
Methodology
Descriptive and transversal case study, with qua-
litative approach, to obtain data on the patients 
clinical history. The data was obtained with a clinical 
interview with the patient, held in February 2nd, 
2015 and February 4th, 2015, at CAPES III, during 
her usual therapy sessions.
Case report
M.C.B.G, female, 29 years old, white, from Asssaré 
–Ceará, living in Juazeiro do Norte– Ceará. Had a 
first visit to office in the CAPES III in March 9th 2006, 
for semi-intensive treatment for audio and visual ha-
llucinations, delirious and megalomaniac ideas, with 
initial diagnostic hypothesis of schizophrenia. 
Patient told us that the trigger of her “problems” 
was an attempt of sexual abuse, suffered when she 
was 16 years old and lived in Rio de Janeiro – RJ. 
Even though she said it was a frustrated attempt, 
the unpleasant experience changed her from this 
moment and on, and made her “like that”. 
Researchers have never come to a consensus 
about the definitive cause of schizophrenia; it is 
known that it is a multifactorial disease, even when 
it has a sudden beginning. Some situations, depen-
ding on its force and frequency, can act like tri-
ggers to symptoms that was previously unnoticed 
for most people. 
MC.BG. has an active social life, engaged in re-
ligious groups, practice physical exercises regularly 
(following medical orders) but still has difficult in her 
familial relationships. She lives with her husband, 
who also is a patient in CAPS III, in a rented house, 
provided with basic services. She told us her dream 
was to become a mother on day, being whiling 
to face all difficults that eventually come with it, 
including in her treatment, being aware of her limi-
tations as an schizophrenic and conscious about the 
need of never stopping her medications.
She is on medical for longer than six years. She 
denies any other morbid past history. Is indepen-
dent in her basic and elementary diary life tasks, as 
breathing, eating, evacuating, moving, dressing and 
undressing her clothes. Usually has four meils in a 
day, with no alimentary restrictions. She denies use 
of psychoactive substances (alcohol, tobacco and 
illegal drugs). She refers important weight gain after 
schizophrenia’s treatment.
She reports a familial medical history of psy-
chiatric problems in her mother and drug abuse 
(alcohol and illegal drugs) in her brother. She was 
collaborative and fully comunicative during the in-
terview. She has a good hygiene patterns, with 
daily showers.
 Her physical exam had no significant altera-
tions. Routine laboratorial exams were also normal. 
She was currently using 2mg daily of Risperidone, 
100mg of Clorpromazine (coloquei o nome da subs-
tância, pois Amplictil é nome do Mercado brasileiro) 
and 20mg of Omeprazole. 
Mental Exam
General
–  Appearence: patient presented with good hygie-
ne conditions. She was calm and collaborative, 
with her eyes down, but with a penetrating loo-
king towards the interviewers. 
–  Verbal action: she demonstrated a coherent speech, 
with organized and spontaneous thoughts, but 
with and fast changes of subject, making some 
her lines incomprehensible sometimes.
–  Humor, sentiment and affect: Patient presents 
with stable humor and adequated affect.
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–  Perception: patient presents (no momento da en-
trevista??) disturbed perception, manifested by 
hallucinations and delirious. 
Thinking process: she displays organized thoughts 
and ideias, but with an accelerated course. 
Sensory and Cognition
– Consciousness: patient was conscious. 
–  Orientation: she appeared to be oriented about 
time, place and person.
–  Concentration and cognition: Due to the limited 
time we had with the patient, it is difficult to 
know if she has difficult in accomplishing her 
group therapy’s activities, but, according with 
herself, she has trouble in some tasks, as in rea-
ding a book, for an example.
–  Memory: no altered memory was noticed during 
evaluation.
–  Inteligence: good level of intelectuality, according 
to the interviewers.
–  Insight: Sheis aware of her moments of “crisis”. 
She has an expectative of getting healed. She 
admits that she is “fine”, and thinks she is not 
able to leaving the health care service because 
of her husband, whom sometimes also get into 
“crisis”.
–  Credibility: Comparing the data presented by the 
patient in the interview, and the data verified 
in medical registries that is no incongruences. 
There so, the patient has credibility reporting her 
situation clearly. 
To help in the patient assistance, the Matricidal 
Support Team of Núcleo de Apoio à Saúde da Fa-
mília (NASF) –a support service to basic health care 
assessments– to collaborate with a singular thera-
peutic plan that could help her best. After initial 
evaluation, patient Body Mass Index (BMI) was 
found to be compatible with Grade I Obesity, and 
she had an appointment with a Nutritionist, who 
prescribed her a healthier diet to help in weight 
control. A physical educating professional was also 
called and oriented the patient about exercise prac-
tice that was adequate for her.
Psychiatrists and Psychologists of CAPS III were 
also involved in the therapeutic plan, contributing 
to patients improvement in self-steem and familial 
relationships. The Centro de Referência de Assistên-
cia Social (CRAS) – a social assistence service – was 
also invited to contribute, and was able to invol-
ve the patient and the patient’s family in activities 
that improved family linkages – the patients’ mother 
and brother were actively searched and included 
for evaluation and treatment in proper Psychosocial 
Centers (in the brother’s case, in the CAPS Alcohol 
and Drugs).
The patient was also referred to an obstetric 
evaluation, regarding her gestational desire and 
treatment adjustments in case she gets pregnant. 
Currently, she is following treatment for Polycistic 
Ovaries Syndrome and fertilization, so she can be-
come a mother. She has lost 3 kilograms after the 
Singular Therapeutic Plan and is optimistic to achie-
ve her ideal weight. 
Patients have a good and trusty relationship with 
the assistance professionals, adhering properly to 
the agreed therapeutic plan. She is still engaged 
with her religious group, is following her diet and 
exercises daily in a gym near to her house and also 
has frequent water aerobics classes. After new la-
boratorial tests, her levels of total cholesterol, HDL-
cholesterol and triglycerides have decreased. Her 
mother is also following treatment in the CAPS III, 
but her brother left his treatment in his drug addiec-
ted suport group. There so, the relationship with her 
mother and other relatives was straightened after 
the insertion in the therapeutic groups in the CRAS. 
M.C.B.G presented improvements in ther cognition, 
concentrative capacitive and self-stem. Yet she re-
ports important gastric symptoms during treatment, 
despite the use of Omeprazole. 
Discussion
Patients diagnosis was based in her symptoms of 
delirious, hallucinations (auditory and visual) and 
megalomaniac ideas. Schizoaffective disorders was 
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also diagnosed, according to the observed and re-
ported symptoms during patients follow-up by the 
CAPS III team, that included profound apathy and 
social isolation.
The patients’ life trajectory by itself may have 
contributed to the development of Schizophrenia. 
Sexual abuse (even if partialy frustrated), familial ne-
gligence and first degree history of psychiatric disor-
ders, family disruption, among many other factors 
reported by the patient an her relatives can act as 
potential triggers for schizophrenia and depression. 
According to Silva (2006), schizophrenia is an he-
reditary disease. Having a parent suffering with the 
disease is the most consistent and important risk 
factor to develop schizophrenia. A clear relationship 
can be found between risk of schizophrenia and 
degree of kinship to a sick relative [13]. 
The relatively stable financial situation –after in-
clusion in welfare policies– brought tranquility to 
the patient and her husband. There were no reports 
of arguments or disagreements between the cou-
ple, which probable helped in their assiduity to the 
activities in CAPS III.
A proposed factor for her schizoaffective disorder 
is the presence of gynecological problems that hin-
der the achievement of pregnancy. Meantime, the 
impossibility of stopping her anti-psychotic meds 
can interfere importantly in an eventual pregnancy. 
 Currently, the efforts of the team were in-
creased to help patients, as the one reported in 
here, that are in the wiling of having children. It is 
believed that achieving their dreams is important 
to reduce symptoms of both schizophrenia and 
depression, as the follow-up is maintained during 
periods of sensitive changes. 
Weight gain is another factor contributing to 
lowering patient’s self-stem in general and in de-
pression. Sedenctarism, unbalanced diet and the 
use of certain anti-psychotic drugs acts sinergica-
lly towards weight gain and are very common in 
schizophrenic patients [14] . According to Atuxx et 
al. (2009) drug therapy can contribute to weight 
loss, however, an multimodal approach to weight 
control, with contextualized flexibility, may produce 
better results [14]. 
In the present case, the adoption of a few measu-
res –allied to the strengthening of ties with the as-
sistance team– were able to help the patient achie-
ve body and psychic changes, making her realize 
that a healthier lifestyle is possible and that she can 
lose weight despite the use of medication.
Finally, with this case’s results, the importance 
of an individual and holystic approach, for patients 
with schizophrenia and other psychotic disorders, 
is reinforced.
Typically Schizoaffective Schizphrenia
Despite the fact that schizophrenic patients also 
suffering from depression have presented an dimi-
nished scores of quality of life, the patterns was 
similiar to those of schizophrenic patients not su-
ffering from depression. Regarding the satisfaction 
with their work, religion, safety and finances, there 
were no significant differences between schizophre-
nic patients who were and weren’t suffering of de-
pression [15].
According to González and Pinto (1998), during 
its initial stages or in transversal evaluation, the 
Schizoaffective Disorder diagnosis can be a com-
plex task, especially in face of its many differential 
diagnosis in the psychotic disorders spectrum [16]. 
Many studies have suggested that patients with 
Schizoaffective disorder and schizophrenia have 
more in common with those having only schizo-
phrenia than with those with bipolar disorder, 
especially in the initial stages. However, cognitive 
and perception disturbances were more intense in 
schizophrenics than in patients with schizoaffective 
disorders and bipolar depression [17]. 
Those same studies indicate that the variables 
related to clinical evolution in the three groups 
are more related between schizoaffective disorder 
and bipolar disease, despite the fact that the acute 
symptoms are more similiar between schizophrenia 
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and schizoaffective disorder. The percent of hospi-
talization were similar in the three groups [18]. 
The pharmacological treatment of Schizoaffective 
Disorder is based on anti-psychotic drugs, humor 
stabilizers and anti-depressives. Clinical trials usua-
lly considered patients with humor disorders and 
schizophrenia, being hard to find in the literature 
studies considering only schizoaffective disorder pa-
tients [19-23].
Depression is frequently associated with a low 
self-stem, future incertaints and a feeling that “life 
is hard”, exercing negative influence in the patients 
perception of his quality of life. Besides that, the 
evaluation of depressive symptoms in schizophrenic 
patients is hard, since its symptoms are “contami-
nated” by the negative manifestations of schizo-
phrenia itself or extrapyramidal symptoms, which 
represent a frequent source of bias [1, 24-27]. 
Greater attention must be dismissed to patients 
with anxiety and depressive symptoms and schizo-
phrenia, considering its greater impact in ther qua-
lity of life –even bigger than negative and positive 
symptoms of schizophrenia. These are potentially 
modifiable factors, when specific therapeutics are 
adopted– which can imply in significant improve-
ments in quality of life in this population [1, 28-30]. 
The psychiatrist is one of the professionals that 
can contribute the most for the improvement in 
those patients’ clinical condition. The psychiatric 
treatment must be associated with a multiprofes-
sional team assistance, which reinforces the impor-
tance of the intersectoriality of health care systems 
for the treatment and follow up of those cases 
[30]. 
Conclusions
Throughout this case it is possible to understand 
more about th Schizoaffective Disorders. Inasmuch, 
these paper showed an holistic vision in the patient’s 
assistance, with as medical approach there is more 
than just “technique and drugs”. 
The followed approach, realized with a multi-
professional assistance team, was favorable to the 
patients prognosis. In clinical practice, and indivi-
dual-focalized and humanized approach, assisting 
the patient as singular being, that deserves respect 
and qualified assistance, is the best one achieving 
their biopsychosocial needs.
Promotion of health care is not made necessa-
rily only through technical procedures, in a hospital 
bed or in an office. Listening carefully, involving the 
family, respecting the patients, their ills, achieving 
confidence and straightening linkages are elements 
that can be used to improve the quality of assistan-
ce, especially in psychiatric patients. 
Legal and Ethical Aspects
The presented study followed all the determina-
tions of Resolution 466/12 of the National Coucil 
of Health/Ministry of Health. The study was sent to 
Plataforma Brasil and than to local Ethics Commit-
tee for Researches involving Human Beings, being 
finally approved. The patient have authorized the 
present study and its use for scientific porpose, ha-
ving signing the Informed Consent Form.
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